[1]
“Determination of Rivaroxaban in pure, pharmaceutical formulations and human plasma samples by RP-HPLC”, Int J of Adv in Phar Ana, vol. 5, no. 3, pp. 65–68, Sep. 2015, doi: 10.7439/ijapa.v5i3.2800.